Method and apparatus for sampling cell cultures from fixed bed reactors
Structurally defined porous substrates in bioreactors address uniform cell distribution and harvesting issues, enhancing scalability and productivity in large-scale cell culture processes.
Patent Information
- Application Number
- JP2024531509
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-30
- Filing Date
- 2022-11-21
- Publication Date
- 2024-11-15
AI Technical Summary
Existing bioreactor systems face challenges in achieving uniform cell distribution, nutrient delivery, and efficient cell harvesting, particularly in packed bed bioreactors, which affect scalability and productivity for large-scale cell culture processes.
The use of structurally defined, ordered arrays of porous substrates in bioreactors allows for uniform cell seeding, nutrient perfusion, and efficient cell harvest, featuring a woven mesh with well-defined apertures and a sampling mechanism for aseptic substrate removal.
This approach enables high-yield, uniform cell culture with consistent performance across scales, facilitating efficient harvesting and monitoring of cell culture processes, thereby reducing production costs and time.
Smart Images

Figure 2024542605000001_ABST
Abstract
Description
Priority
[0001] This application claims the benefit of priority under 35 U.S.C. § 119 of U.S. Provisional Patent Application No. 63 / 284371, filed November 30, 2021, U.S. Provisional Patent Application No. 63 / 284256, filed November 30, 2021, and U.S. Provisional Patent Application No. 63 / 284169, filed November 30, 2021, the contents of which are relied upon and incorporated herein by reference in their entireties. [Technical field]
[0002] The present disclosure relates generally to substrates for culturing cells, and bioreactors for housing same, that allow for sampling of the substrate during cell culture. In particular, the disclosure relates to cell culture substrates and bioreactors incorporating such substrates that allow for removal of samples from the bioreactor to allow for sterile sampling of portions of the substrate during and / or after cell culture processes to monitor the health and progress of the culture and other processes. [Background technology]
[0003] The bioprocessing industry involves the large-scale cultivation of cells for the production of hormones, enzymes, antibodies, vaccines, and cell therapy. The cell and gene therapy market is growing rapidly, with promising treatments entering clinical trials and rapidly moving towards commercialization. However, a single cell therapy dose can require billions of cells or trillions of viruses. Therefore, being able to provide large amounts of cell products in a short time frame is crucial for clinical success.
[0004] The majority of cells used in bioprocessing are anchorage-dependent, meaning that they require a surface to attach to in order to grow and function. Traditionally, culture of adherent cells is performed on two-dimensional (2D) cell-adhesive surfaces incorporated into one of a number of vessel formats, such as T-flasks, Petri dishes, cell factories, cell stacking vessels, roller bottles, and HYPERStack® vessels. These approaches can have significant deficiencies, including the difficulty of achieving a cell density high enough to make large-scale production of therapeutics or cells feasible.
[0005] Alternative methods have been proposed to increase the volumetric density of cultured cells. These include microcarrier culture, which is carried out in a stirred tank. In this approach, cells attached to the surface of the microcarriers are exposed to constant shear stress, which has a significant impact on growth and culture performance. Another example of a high-density cell culture system is the hollow fiber bioreactor, where cells can form large three-dimensional aggregates as they grow within the open fiber spaces. However, cell growth and performance are severely hindered by nutrient starvation. To alleviate this problem, these bioreactors are made small and are not suitable for large-scale manufacturing.
[0006] Another example of a high-density culture system for anchorage-dependent cells is the packed-bed bioreactor system. In this type of bioreactor, a cell substrate is used to provide a surface for the adherent cells to attach to. Culture medium is perfused along the surface or through the semi-porous substrate to provide the nutrients and oxygen required for cell growth. For example, packed-bed bioreactor systems containing a packed bed of a support or matrix system for entrapping cells have already been disclosed in US Pat. Nos. 5,999,103, 5,943, 5,951, 5,963, 5,971, 5,982, 5,995, 6,996, 7,997, 8,998, 9,999, 10,102, 11,113, 12,121, 13,146, 14,151, 15,162, 16,171, 17,182, 18,197, 19,199, 20,202, 21,227, 23,241, 24,251, 25,261, 26,271, 27,281, 28,297, 29,302, 29,313, 29,326, 29,332, 29,341, 29,351, 29,361, 29,371, 29,382, 29,397 ...61, 29,371, 29,382, 29,397, 29,361, 2 This creates a channeling effect whereby nutrients and oxygen are delivered more efficiently to areas of low volumetric cell density, while areas of high cell density are maintained in suboptimal culture conditions.
[0007] Another significant drawback of the packed bed systems disclosed in the prior art is the inability to efficiently harvest intact viable cells at the end of the culture process. Cell harvesting is important when the end product is cells or when the bioreactor is used as part of a "seed train" (where a population of cells is grown in one vessel and then transferred to another vessel for further population growth). US Patent No. 5,999,943 discloses a bioreactor design to improve the efficiency of cell recovery from a packed bed during the cell harvesting process. The design is based on loosening the packed bed matrix and rocking or agitating the packed bed particles to collide with the porous matrix and thus detach the cells. However, this approach is time-consuming and laborious and will significantly damage the cells, thus reducing overall cell viability.
[0008] Some existing bioreactor solutions use small pieces of cell substrate material consisting of randomly oriented fibers in a non-woven arrangement. These pieces are packed into a vessel to create a packed bed. However, like similar solutions on the market, this type of packed bed substrate also has drawbacks. In particular, uneven packing of the substrate pieces creates visible channels in the packed bed, resulting in preferential and uneven medium flow and nutrient distribution through the packed bed. Studies of such systems have noted "systematic uneven distribution of cells, with increasing numbers from the top to the bottom of the fixed bed," as well as "nutrient gradients...resulting in limited cell growth and production," all of which "can impair transfection efficiency due to uneven distribution of cells" (Non-Patent Document 1). Studies have shown that rocking the packed bed can improve dispersion, but there may be other drawbacks (i.e., "the rocking required to achieve good dispersion during inoculation and transfection induces increased shear stresses, which in turn may reduce cell survival" ibid.). Another study noted that uneven distribution of cells makes it difficult to monitor cell populations using biomass sensors ("...if the cells are unevenly distributed, the biomass signal from the cells on the upper carrier may not give a general view of the whole bioreactor" Non-Patent Document 2).
[0009] In addition, the random placement of fibers within the substrate pieces and variability in particle packing from one packed bed to another in bioreactors such as those described above can make it difficult for customers to predict cell culture performance as the substrates will vary from culture to culture. Furthermore, randomly packed substrates, which themselves have random structure, can make it very difficult or impossible to efficiently harvest cells as the cells will become trapped by the packed bed. [Prior art documents] [Patent documents]
[0010] [Patent Document 1] U.S. Pat. No. 4,833,083 [Patent Document 2] U.S. Patent No. 5,501,971 [Patent Document 3] U.S. Pat. No. 5,510,262 [Patent Document 4] U.S. Patent No. 9,273,278 [Non-patent literature]
[0011] [Non-Patent Document 1] Rational plasmid design and bioprocess optimization to enhance recombinant adeno-associated virus (AAV) productivity in mammalian cells. Biotechnol. J. 2016, 11, 290-297 [Non-Patent Document 2] Process Development of Adenoviral Vector Production in Fixed Bed Bioreactor: From Bench to Commercial Scale. Human Gene Therapy, Vol. 26, No. 8, 2015 Summary of the Invention [Problem to be solved by the invention]
[0012] While existing platforms are capable of producing viral vectors for early-phase clinical trials, to reach late-stage commercial scale, platforms capable of producing large quantities of high-quality product are required.
[0013] In addition, it is desirable to be able to monitor bioreactors used to culture cells or to create seed trains to manufacture AAV or promote cell growth for biochemical production. When using adherent cell reactors, samples of growth medium do not contain cells, or at least do not contain cells to an extent that is useful for monitoring the status of the culture on the adherent substrate.
[0014] What is needed are cell culture matrices, systems, and methods that allow a user to monitor the status of a cell culture process by examining the cells on the substrate during and / or after the cell culture process, including monitoring the substrate in a sterile manner, while allowing for the cultivation of cells in a high density format, with uniform cell distribution and easily achievable and increased harvest yields. [Means for solving the problem]
[0015] According to embodiments of the present disclosure, cell culture substrates are disclosed that allow all or a portion of the substrate to be sampled to monitor the state or health of the cell culture. Embodiments include multi-layer fixed-bed cell culture matrices in which one or more layers are specifically designed to allow for this sampling. Embodiments also include fixed-bed bioreactors comprising such cell culture substrates and / or matrices.
[0016] To be able to predict the number of cells and their distribution and health within an adherent cell bioreactor bed, some methods remove a portion of the substrate during a cell culture or cell growth process. By sampling during the process, information about the cell culture run can be used to evaluate the quality and performance of the process. Cell numbers can be predicted from the samples and growth can be monitored by sampling at different times. This information can be used to develop and optimize the performance of certain biological processes, such as seed trains or viral vector production. In production, contaminated or out-of-spec runs can be terminated to reduce the cost of running the process to completion without satisfactory results. Growth medium and lost production time are significant costs for a typical biological process. An embodiment of the present disclosure allows all or a portion of the fixed bed cell culture substrate to be removed from the enclosure to allow the user to access the bed without disturbing the bed or the bioreactor vessel. This allows any or selected portion of the fixed bed to be evaluated. The bed can also be evaluated after the cell culture process or after harvesting of desired components has been completed for "post-mortem" analysis of the cell culture.
[0017] According to an embodiment of the present disclosure, a fixed-bed bioreactor assembly for culturing cells and sampling of substrates during cell culturing is provided, the fixed-bed bioreactor assembly comprising: a bioreactor vessel having an interior space for culturing cells and a sidewall at least partially defining the interior space; a plurality of cell culture substrate layers disposed within the interior space, each layer having a structurally defined surface for culturing cells thereon, the structurally defined surface defining an ordered regular array of openings through a thickness of the layer; and a sleeve at least partially surrounding the plurality of cell culture substrate layers and having at least one sample access window, the sample access window including an opening in the sleeve configured to allow one or more layers of cell culture substrate to be removed from the sleeve through the opening.
[0018] According to an embodiment of the present disclosure, a method of sampling a cell culture substrate from a bioreactor vessel is provided, the method comprising the steps of: removing a sleeve of stacked cell culture substrate layers from the bioreactor vessel through a top or bottom of the bioreactor vessel; removing one or more layers of the cell culture substrate through a sample access window disposed on a side of the sleeve, the sample access window being an opening formed in the sleeve exposing at least a portion of the cell culture substrate layers.
[0019] According to an embodiment of the present disclosure, a fixed-bed bioreactor system for culturing cells is provided, the system comprising: a bioreactor vessel having an interior space for culturing cells and a sidewall at least partially defining the interior space, at least one port in the sidewall of the bioreactor vessel, a cell culture substrate disposed within the interior space, and a sampling reel disposed exterior to the bioreactor vessel, the sampling reel adapted to rotate about a central axis to aseptically remove a sample substrate from the interior space.
[0020] According to aspects of the embodiment, the sampling reel includes a through opening through which the substrate sample can pass from the interior space to the sampling reel. The sampling reel can be fixed to the exterior of the bioreactor vessel wall via a saddle housing forming at least a portion of the outer shell of the sampling reel. The through opening of the sampling reel is aligned with at least one port of the bioreactor vessel. The sampling reel further includes a housing cap forming at least a portion of the outer shell of the sampling reel. The sampling reel further includes a sample opening disposed between the housing cap and the saddle housing. The sample opening is configured to allow the substrate sample to be removed from the sampling reel to the exterior of the bioreactor system through the sample opening. The sampling reel further includes a spool configured to grip a portion of the sample substrate, the spool being rotatable such that the sample substrate is wound onto the spool when the spool rotates. The sampling reel further includes a sample drum disposed between the spool and the outer shell of the sampling reel. The sampling reel may further include a series of stationary O-rings secured to the saddle housing and adapted to form a seal in the space between the saddle housing and the sample drum to allow for sterile sampling of the sample substrate.
[0021] According to aspects of the embodiment, the sample drum further includes a drum opening configured to allow the sample substrate to pass through the sample drum to the spool. The sampling reel is configured to rotate in a first direction to remove the sample substrate from the interior space and rotate in a second direction opposite the first direction to eject the sample substrate from the sampling reel to the exterior of the bioreactor system. The substrate sample is removed through the opening in the sampling reel to the exterior of the bioreactor system by a curved or wedge surface on the edge of the through opening.
[0022] According to an embodiment of the present disclosure, a fixed-bed bioreactor system for culturing cells is provided. The system includes a bioreactor vessel having an interior space for culturing cells and a sidewall at least partially defining the interior space; at least one port in the sidewall of the bioreactor vessel; and a cell culture substrate disposed within the interior space and having a structurally defined surface for culturing cells thereon, the structurally defined surface defining an ordered regular array of openings through a thickness of the cell culture substrate. At least a portion of the cell culture substrate includes a sample substrate, the sample substrate being defined by a separation boundary between the sample substrate and a remainder of the cell culture substrate. The separation boundary is configured to separate the sample substrate from the remainder of the cell culture substrate, and the at least one port is sized to allow removal of the sample substrate from the interior space through the at least one port.
[0023] According to various aspects of the embodiments of the present disclosure, the separation boundary comprises at least one of the following: a perforation, a cut in or through the cell culture substrate, or a locally thinned portion thereof. The separation boundary may further comprise an attachment material between the sample substrate and the remainder of the substrate, the attachment material adapted to detach from one or both of the sample substrate and the remainder of the substrate under tension. The system may further comprise a plurality of sample substrates. At least two of the plurality of sample substrates may be separated from one another with a portion of the remainder of the cell culture substrate that is not one of the plurality of sample substrates. At least some of the plurality of sample substrates may be separated from one another at the separation boundary without any of the remainder of the cell culture substrate that is not one of the plurality of sample substrates therebetween.
[0024] The bioreactor vessel is adapted to aseptically remove the sample substrate from the interior space. The system may include a tether including a first end attached to the sample substrate, the tether adapted to pull the sample substrate from the interior space through the port. The system may further include a capture device disposed outside the interior space and adapted to contain the sample substrate after it is removed from the interior space through at least one port. The capture device may have a flexible wall, pleated wall, or folded structure that allows the capture device to have a variable interior volume. The system may further include a plug disposed along the tether between the first and second ends of the tether, the plug adapted to form a sterile seal in the port while the sample substrate remains within the interior space. The plug adapted to be removed from the port when the second end of the tether is pulled away from the port with a predetermined force. [Brief description of the drawings]
[0025] [Figure 1A] FIG. 1 is a perspective view of a three-dimensional model of a cell culture substrate according to an embodiment of the present disclosure. [Figure 1B] 2D plan view of the substrate of FIG. 1A [Figure 1C] 1B is a cross-sectional view of the substrate taken along line AA in FIG. [Diagram 2] FIG. 1 is an illustration of a cell culture system according to an embodiment. [Figure 3A] 1 is a top view of a sample layer of a cell culture substrate, with a separation boundary defining a substrate sample portion, according to an embodiment; [Figure 3B] 3B is a top view of the sample layer and sample portion of the cell culture substrate of FIG. 3A after the sample portion has been separated from the remainder of the sample layer of the substrate, according to an embodiment. [Figure 4A] 1 is a top view of a sample layer of a cell culture substrate with multiple substrate sample portions having tapered ends, according to an embodiment; [Figure 4B] FIG. 4B shows an individual substrate sample portion from FIG. [Figure 4C]FIG. 4C shows the individual substrate sample portions of FIG. 4B and the ports through which the substrate sample portions can be withdrawn from the fixed-bed cell culture substrate. [Figure 5A] FIG. 1 illustrates a sidewall of a cell culture vessel having multiple ports for accessing portions of a cell culture sample within an interior chamber of the vessel, according to an embodiment. [Figure 5B] 5B is a cross-sectional view of the sidewall of FIG. 5A taken along line AA of FIG. 5A, according to an embodiment. [Figure 6A] FIG. 1 is an isometric view of a bioreactor with a series of sampling reels on the side of the bioreactor, according to an embodiment. [Figure 6B] FIG. 6B is an enlarged isometric view of one of the sampling reels from FIG. 6A, according to an embodiment; [Figure 7] FIG. 6C is a cross-sectional view of the sampling reel from FIG. 6B, according to an embodiment; [Figure 8A] 8 is a cross-sectional view of the sampling reel of FIG. 7 in a rotating state to remove a sample substrate, according to an embodiment. [Figure 8B] FIG. 8B is a cross-sectional view of the sampling reel of FIG. 8A after the sample substrate has been removed. [Figure 9A] 7-8B after the sampling reel has been rotated to align the substrate sample opening with the housing opening to allow removal of the substrate sample, according to an embodiment. [Figure 9B] FIG. 9B is a cross-sectional view of the sampling reel of FIG. 9A after counterclockwise rotation to generate a sample substrate, according to an embodiment. [Figure 10A] 1 is a cross-sectional view illustrating a sample substrate emerging from a substrate sample opening, according to an embodiment; [Figure 10B] FIG. 10B is a cross-sectional view of the sampling reel of FIG. 10A after the sample substrate has been removed, according to an embodiment. [Figure 11A] FIG. 1 illustrates a spool in position to receive a sample substrate from a bioreactor, according to an embodiment. [Figure 11B] FIG. 1 illustrates a spool in a closed position, according to an embodiment. [Figure 11C] 11A and 11B, with the spool in position to produce a sample substrate from the reel, according to an embodiment. [Figure 12A] FIG. 1 is an isometric view of a multi-layer cell culture substrate assembly in a sleeve with cutouts for sampling, according to an embodiment. [Figure 12B] Top view of the assembly of FIG. [Figure 13A] FIG. 12B is an isometric view of the assembly of FIG. 12A with a seal along the notch, according to an embodiment. [Figure 13B] Top view of the assembly of FIG. 13A [Figure 14A] FIG. 13B is an isometric view of the assembly of FIG. 13A positioned within the outer housing of a bioreactor vessel, according to an embodiment. [Figure 14B] Top view of the assembly of FIG. [Figure 15] FIG. 14B is an isometric view of the assembly of FIG. 14A with the multi-layer cell culture substrate and sleeve lifted from the housing of the bioreactor vessel for sampling, according to an embodiment. [Figure 16] FIG. 1 is a top view of a substrate sample cartridge assembly, according to an embodiment; [Figure 17] 1 is a top view of a substrate sample layer with sample portions tethered thereto, according to an embodiment; [Figure 18A] Photograph of a substrate sample layer of woven PET mesh according to an embodiment [Figure 18B] Photograph of a sample section stained with crystal violet of a woven PET mesh prior to harvesting of adherent cells, according to an embodiment. [Figure 18C] Photograph of a crystal violet stained sample section of a woven PET mesh substrate after harvesting of adherent cells according to an embodiment. [Figure 19A] FIG. 1 is a cross-sectional view of a sample capture device attached to a sidewall of a bioreactor for receiving a sample portion from within the reactor, according to an embodiment. [Figure 19B] FIG. 19B is a cross-sectional view of the sample capture device of FIG. 19A receiving a sample portion from within a reactor, according to an embodiment. [Figure 19C] 19C is a cross-sectional view illustrating attachment of a sample portion to a bioreactor around a tether of the sample capture device of FIGS. 19A and 19B, according to an embodiment; [Figure 20A]1 is a cross-sectional view of another sample capture device according to an embodiment; [Figure 20B] FIG. 20B illustrates the sample capture device of FIG. 20A in the process of attaching it to a tether of a sample portion for removal. [Figure 20C] 20A and 20B after removing the sample portion from the bioreactor and sealing the sample capture device, according to an embodiment. [Figure 21A] FIG. 13 is a cross-sectional view of a sample capture device attached to a sidewall of a bioreactor with a valve cam ring for sealing a port after removing a sample portion, according to an embodiment. [Figure 21B] FIG. 21B is a cross-sectional view of the valve cam ring of FIG. 21A, according to an embodiment. [Figure 21C] 21A and 21B, according to an embodiment, a cross-sectional view of the sample capture device after removing the sample portion and closing the valve cam ring of FIGS. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0026] Various embodiments of the present disclosure will now be described in detail, with reference to the drawings, if any. Reference to various embodiments is not intended to limit the scope of the invention, which is limited only by the claims appended hereto. In addition, any examples set forth herein are not limiting, but merely set forth some of the many possible embodiments of the claimed invention.
[0027] Embodiments of the present disclosure include cell culture substrates as well as cell culture bioreactors incorporating such substrates that allow for sampling of the substrate or portions of the substrate to monitor the cell culture.
[0028] In conventional large-scale cell culture bioreactors, different types of packed bed bioreactors have been used. Typically, these packed beds contain a porous matrix to support the growth and proliferation of attached or suspended cells. The packed bed matrix provides a high surface area to volume ratio, and thus the cell density can be higher than in other systems. However, the packed bed often acts as a depth filter, where the cells are physically trapped or enmeshed in the fibers of the matrix. Therefore, due to the linear flow of the cell inoculum through the packed bed, the cells are exposed to a non-uniform distribution within the packed bed, resulting in cell density variations across the depth or width of the packed bed. For example, the cell density will be higher at the inlet region of the bioreactor and significantly lower near the outlet of the bioreactor. Such non-uniform distribution of cells inside the packed bed can significantly hinder the scalability and predictability of such bioreactors in bioprocess manufacturing, and even result in reduced efficiency in terms of cell growth or viral vector production per unit surface area or volume of the packed bed.
[0029] Another problem encountered in packed bed bioreactors disclosed in the prior art is the channeling effect. The local fiber density at any given cross section of the packed bed is not uniform due to the randomness of the packed nonwoven fibers. The medium flows faster in areas of low fiber density (high bed permeability) and much slower in areas of high fiber density (lower bed permeability). The resulting non-uniform medium perfusion across the packed bed creates a channeling effect, which is manifested as a significant gradient of nutrients and metabolites that negatively impacts the overall cell culture and the performance of the bioreactor. Cells located in areas of low medium perfusion will starve and very often die due to nutrient deficiency or metabolite poisoning. Cell harvest is yet another problem encountered when bioreactors packed with nonwoven fiber scaffolds are used. Cells released at the end of the cell culture process are trapped inside the packed bed due to the packed bed functioning as a depth filter and cell recovery is very low. This severely limits the use of such bioreactors in bioprocesses where live cells are the product. Hence, non-uniformity results in areas of different exposure to flow and shear, effectively reducing the available cell culture area, resulting in non-uniform cultures and impeding transfection efficiency and cell release.
[0030] To address these and other problems of existing cell culture solutions, embodiments of the present disclosure provide cell growth substrates, matrices of such substrates, and / or packed bed systems using such substrates that enable efficient and high yield cell culture of anchorage-dependent cells and production of cell products (e.g., proteins, antibodies, viral particles). Embodiments include porous cell culture matrices fabricated from regular ordered arrays of porous substrate materials that enable uniform cell seeding and medium / nutrient perfusion, as well as efficient cell harvesting. Embodiments also provide scalable cell culture solutions in terms of substrates and bioreactors that can seed and grow cells and / or harvest cell products from process development scale to full production size scale without sacrificing the uniform performance of the embodiments. For example, in some embodiments, bioreactors can be configured to produce equivalent viral genomes per unit surface area of substrate (VG / cm) from process development scale to production scale. 2 ) to production scale. The yield stability and scalability of the embodiments described herein allow for efficient seed trains to be used to grow cell populations at multiple scales on the same cell substrate. Additionally, the embodiments described herein provide cell culture substrates with high surface area that, in combination with other features described, enable high yield cell culture solutions. In some embodiments, for example, the cell culture substrates and / or bioreactors described herein can be used to grow 1000 cells per batch. 16 From 10 18 It can produce viral genomes (VG).
[0031] In embodiments, matrices are provided that have a structurally defined surface area for adherent cells to attach and grow, have good mechanical strength, and form a highly uniform, multi-interconnected fluidic network when assembled in a packed bed or other bioreactor. In certain embodiments, mechanically stable, non-degradable woven meshes can be used as substrates to support adherent cell production. The cell culture matrices disclosed herein support attachment and growth of anchorage-dependent cells in a high volumetric density format. Uniform cell seeding of such matrices, as well as efficient harvesting of cells or other products of the bioreactor, can be achieved. In addition, embodiments of the present disclosure provide uniform cell distribution during the seeding process and support cell culture to achieve a confluent monolayer or multilayer of adherent cells on the disclosed matrices, avoiding the formation of large and / or uncontrollable 3D cell aggregates with limited nutrient diffusion and increased concentrations of metabolites. Hence, the matrix eliminates diffusion limitations during the operation of the bioreactor. In addition, the matrix allows for easy and efficient cell harvesting from the bioreactor. The structurally defined matrix of one or more embodiments allows for complete cell recovery and consistent cell harvest from the packed bed of the bioreactor.
[0032] According to embodiments, there is also provided a cell culture method using a bioreactor having a matrix for bioprocessing production of a therapeutic protein, an antibody, a viral vaccine, or a viral vector.
[0033] In contrast to existing cell culture substrates used in cell culture bioreactors (i.e., non-woven substrates of randomly ordered fibers), embodiments of the present disclosure include cell culture substrates having a well-defined ordered structure. The well-defined ordered structure results in consistent and predictable cell culture results. Additionally, the substrate has an open porous structure that prevents cell entrapment and allows uniform flow through the packed bed. This configuration can improve cell seeding, nutrient delivery, cell growth, and cell harvest. According to one or more particular embodiments, a matrix is formed of substrate material having a thin sheet-like structure with first and second sides separated by a relatively small thickness, such that the thickness of the sheet is small relative to the width and / or length of the first and second sides of the substrate. Additionally, a plurality of holes or openings are formed through the thickness of the substrate. The substrate material between the openings is sized and shaped to allow cells to attach to the surface of the substrate material as if it were a substantially two-dimensional (2D) surface, while allowing suitable fluid flow around and through the openings of the substrate material. In some embodiments, the substrate is a polymer-based material and may be formed as a molded polymer sheet; a polymer sheet with holes drilled through its thickness; multiple filaments fused into a mesh-like layer; a 3D printed substrate; or multiple filaments woven into a mesh layer. The physical structure of the matrix has a high surface area to volume ratio for culturing anchorage-dependent cells. According to various embodiments, the matrix can be arranged or packed into a bioreactor in a specific manner as described herein for uniform cell seeding and growth, uniform medium perfusion, and efficient cell harvesting.
[0034] The embodiments of the present disclosure are 14 More than 10 viral genomes per batch 15 More than 10 viral genomes per batch 16 More than 10 viral genomes per batch 17 More than 10 viral genomes per batch, or approximately 10 16 It is possible to achieve a practical size viral vector platform capable of producing viral genomes on a scale up to or exceeding 10 viral genomes. In some embodiments, production can be achieved at a scale of about 10 per batch.15 About 10 18 For example, in some embodiments, the viral genome yield is about 10 15 About 10 16 of viral genomes, or approximately 10 per batch. 16 About 10 19 of viral genomes, or approximately 10 per batch. 16 About 10 18 of viral genomes, or approximately 10 per batch. 17 About 10 19 of viral genomes, or approximately 10 per batch. 18 About 10 19 of viral genomes, or approximately 10 per batch. 18 The viral genome may be any of the above.
[0035] Additionally, the disclosed embodiments allow for cell attachment and growth on the cell culture substrate as well as viable harvesting of cultured cells. The inability to harvest viable cells is a significant drawback of current platforms, which results in difficulties in establishing and maintaining sufficient numbers of cells for production capacity. According to aspects of the disclosed embodiments, viable cells can be harvested from the cell culture substrate, including 80% to 100% viable, or about 85% to about 99% viable, or about 90% to about 99% viable. For example, at least 80% of the harvested cells are viable, at least 85% are viable, at least 90% are viable, at least 91% are viable, at least 92% are viable, at least 93% are viable, at least 94% are viable, at least 95% are viable, at least 96% are viable, at least 97% are viable, at least 98% are viable, or at least 99% are viable. Cells may be released from the cell culture substrate using, for example, trypsin, TrypLE, or Accutase®.
[0036] 1A and 1B show a three-dimensional (3D) perspective view and a two-dimensional (2D) plan view, respectively, of a cell culture substrate 100 according to one or more embodiments of the present disclosure. The cell culture substrate 100 is a woven mesh layer made from a first plurality of fibers 102 extending in a first direction and a second plurality of fibers 104 extending in a second direction. The woven fibers of the substrate 100 form a plurality of openings 106, which may be defined by one or more widths or diameters (e.g., D1, D2). The size and shape of the openings may vary based on the type of weave (e.g., number, shape, and size of filaments; angle between intersecting filaments, etc.). A woven mesh may be characterized as a macro-scale, two-dimensional sheet or layer. However, close inspection of the woven mesh reveals a three-dimensional structure due to the rises and falls of the intersecting fibers of the mesh. 1C, the thickness T of the woven mesh 100 will be greater than the thickness of a single fiber (e.g., t1). As used herein, the thickness T is the maximum thickness between the first side 108 and the second side 110 of the woven mesh. Without intending to be bound by theory, it is believed that because the three-dimensional structure of the substrate 100 provides a large surface area for culturing adherent cells, advantageously, the structural rigidity of the mesh can provide a consistent and predictable cell culture matrix structure that allows for uniform fluid flow.
[0037] In FIG. 1B, the aperture 106 has a diameter D1 defined as the distance between opposing fibers 102, and a distance D2 defined as the distance between opposing fibers 104. D1 and D2 may or may not be equal depending on the weave configuration. If D1 and D2 are not equal, the larger may be referred to as the outer diameter and the smaller may be referred to as the inner diameter. In some embodiments, the diameter of the aperture may refer to the widest portion of the aperture. Unless otherwise specified, the diameter of the aperture, as used herein, will refer to the distance between parallel fibers on opposite sides of the aperture.
[0038] A given fiber in the plurality of fibers 102 has a thickness t1, and a given fiber in the plurality of fibers 104 has a thickness t2. In the case of fibers with a circular cross-section, such as shown in FIG. 1A, or other three-dimensional cross-section, thicknesses t1 and t2 are the maximum diameter or thickness of the fiber cross-section. According to some embodiments, all of the plurality of fibers 102 have the same thickness t1, and all of the plurality of fibers 104 have the same thickness t2. In addition, t1 and t2 can be equal. However, in one or more embodiments, t1 and t2 are not equal, such as when the plurality of fibers 102 is different from the plurality of fibers 104. In addition, each of the plurality of fibers 102 and the plurality of fibers 104 may have two or more different thicknesses (e.g., t 1a , t 1b etc., and t 2a , t 2b In some embodiments, the thicknesses t1 and t2 are large relative to the size of the cells being cultured thereon, and thus the fibers provide an approximation of a plane from the cell's perspective, which allows for better cell attachment and proliferation compared to some other solutions where the fiber size is small (e.g., on the scale of the cell's diameter). Due to the three-dimensional nature of the woven mesh, as shown in Figures 1A-1C, the 2D surface area of the fibers available for cell attachment and proliferation exceeds the surface area for attachment on a comparable flat 2D surface.
[0039] In one or more embodiments, the fibers may have diameters ranging from about 50 μm to about 1000 μm, about 100 μm to about 750 μm, about 125 μm to about 600 μm, about 150 μm to about 500 μm, about 200 μm to about 400 μm, about 200 μm to about 300 μm, or about 150 μm to about 300 μm. At the microscale, due to the scale of the fibers compared to the cells (e.g., the diameter of the fibers is larger than the cells), the surface of a single fiber presents an approximation of a 2D surface for adherent cells to attach and grow on. The fibers can be woven into a mesh with openings ranging from about 100 μm×100 μm to about 1000 μm×1000 μm. In some embodiments, the openings may have a diameter of about 50 μm to about 1000 μm, about 100 μm to about 750 μm, about 125 μm to about 600 μm, about 150 μm to about 500 μm, about 200 μm to about 400 μm, or about 200 μm to about 300 μm. These ranges of filament diameters and opening diameters are examples of some embodiments and are not intended to limit the possible feature sizes of meshes according to all embodiments. The combination of fiber diameter and opening diameter is selected to provide efficient and uniform fluid flow through the substrate, for example, when the cell culture matrix is made from multiple adjacent mesh layers (e.g., a stack of individual layers or rolled mesh layers).
[0040] Factors such as fiber diameter, aperture diameter, and weave / pattern will determine the surface area available for cell attachment and growth. In addition, if the cell culture matrix includes a stack, roll, or other arrangement of overlapping substrates, the packing density of the cell culture matrix will affect the surface area of the packed bed matrix. Packing density can vary depending on the packing thickness of the substrate material (e.g., the space required for a layer of substrate). For example, if a stack of cell culture matrices has a certain height, each layer of the stack can be said to have a packing thickness determined by dividing the total height of the stack by the number of layers in the stack. The packing thickness can vary based on the fiber diameter and weave, but can also vary based on the alignment of adjacent layers in the stack. For example, due to the three-dimensional nature of the knitted layers, there is a certain amount of interlocking or overlap that adjacent layers can accommodate based on the alignment of each other. In a first alignment, adjacent layers can fit tightly together, while in a second alignment, adjacent layers can have no overlap, such as when the lowest point of the top layer is in direct contact with the highest point of the bottom layer. In certain applications, it may be desirable to provide a cell culture matrix with layers that are less densely packed (e.g., where higher permeability is a priority) or more densely packed (e.g., where maximizing the surface area of the substrate is a priority). According to one or more embodiments, the packing thickness can be from about 50 μm to about 1000 μm, from about 100 μm to about 750 μm, from about 125 μm to about 600 μm, from about 150 μm to about 500 μm, from about 200 μm to about 400 μm, or from about 200 μm to about 300 μm.
[0041] The structural factors discussed above can determine the surface area of a cell culture matrix, whether it is a single layer of cell culture substrate or a cell culture matrix having multiple layers of substrate. For example, in certain embodiments, a single layer of a circular, 6 cm diameter woven mesh substrate has a surface area of approximately 68 cm. 2As used herein, "available surface area" is the total surface area of the fibers in a portion of the substrate material available for cell attachment and growth. Unless otherwise specified, references to "surface area" refer to this available surface area. According to one or more embodiments, a single woven mesh substrate layer having a diameter of 6 cm can have an effective surface area of approximately 50 cm. 2 About 90cm from 2 , approx. 53cm 2 From about 81cm 2 , about 68cm 2 , about 75cm 2 , or about 81 cm 2 These ranges of effective surface areas are given by way of example only, and some embodiments may have different effective surface areas. The cell culture matrix may also be characterized in terms of porosity, as described in the Examples herein.
[0042] The substrate mesh can be made from monofilaments or multifilaments of polymeric materials compatible with cell culture applications, including, for example, polystyrene, polyethylene terephthalate, polycarbonate, polyvinylpyrrolidone, polybutadiene, polyvinyl chloride, polyethylene oxide, polypyrrole, and polypropylene oxide. Mesh substrates can have different patterns or weaves, including, for example, knitted, warp knitted, or woven (e.g., plain weave, twill, Dutch weave, five needle weave).
[0043] The surface chemistry of the mesh filaments may need to be modified to provide the desired cell adhesion properties. Such modifications may be accomplished by chemical treatment of the polymeric material of the mesh or by grafting cell adhesion molecules onto the filament surface. Alternatively, the mesh may be coated with a thin layer of a biocompatible hydrogel that exhibits cell adhesion properties, including, for example, collagen or Matrigel®. Alternatively, the surfaces of the filament fibers of the mesh may be imparted with cell adhesion properties through treatment processes with various types of plasmas, treatment gases, and / or chemicals known in the art. However, in one or more embodiments, the mesh may provide an efficient cell growth surface without surface treatment.
[0044] Another advantage of the larger surface area and high cell seeding or growth density is that the cost of the embodiments disclosed herein can be the same or lower than competing solutions, specifically the cost per cell product (e.g., per cell or per viral genome) can be equal to or lower than other packed bed bioreactors.
[0045] By using a structurally well-defined culture matrix with sufficient rigidity, high flow resistance uniformity is achieved throughout the matrix or packed bed. According to various embodiments, the matrix can be installed in a single or multi-layer configuration. This versatility eliminates diffusion limitations and allows for uniform delivery of nutrients and oxygen to cells attached to the matrix. In addition, the open matrix does not allow for any cell entrapment areas in the packed bed configuration, allowing for complete cell harvest with high viability at the end of the culture. The matrix also provides packing uniformity for the packed bed, allowing direct scalability from process development units to large-scale industrial bioprocessing units. The ability to harvest cells directly from the packed bed eliminates the need to resuspend the matrix in a stirred or mechanically shaken vessel, which would add complexity and could impose harmful shear stresses on the cells. Furthermore, the high packing density of the cell culture matrix allows for high bioprocessing productivity in volumes that are manageable at industrial scale.
[0046] As used herein, "structurally defined" means that the structure of the substrate follows a predetermined design and is not random. Thus, a structurally defined substrate may be of woven design, 3D printed, molded, or formed by some other technique known in the art that causes the structure to conform to a predetermined planned structure.
[0047] As described herein, in accordance with one or more embodiments, the cell culture substrate can be used within a bioreactor vessel. For example, the substrate can be used within a packed bed bioreactor structure, or other structure within a three-dimensional culture chamber. However, the embodiments are not limited to three-dimensional culture spaces, and the substrate can be used within what would be considered a two-dimensional culture surface structure, such as within a flat-bottom culture dish, where one or more layers of the substrate are flattened to provide a culture substrate for cells. The vessel can be a disposable vessel that can be discarded after use due to contamination concerns.
[0048] According to one or more embodiments, a cell culture system is provided in which a cell culture matrix is used within a culture chamber of a bioreactor vessel. FIG. 2 shows an example of a cell culture system 300 including a bioreactor vessel 302 having a cell culture chamber 304 therein. Within the cell culture chamber 304 is a cell culture matrix 306 made from a stack of substrate layers 308. The substrate layers 308 are stacked such that a first or second side of one substrate layer faces a first or second side of an adjacent substrate layer. The bioreactor vessel 302 has an inlet 310 at one end for medium, cells, and / or nutrients to enter the culture chamber 304 and an outlet 312 at the opposite end for removing medium, cells, or cell products from the culture chamber 304. By allowing substrate layers to be stacked in this manner, the system can be easily scaled without adversely affecting cell attachment and growth due to the defined structure and efficient fluid flow through the stacked substrates. Although vessel 302 may be generally described as having an inlet 310 and an outlet 312, in some embodiments, one or both of inlet 310 and outlet 312 may be used to flow medium, cells, or other contents into or out of culture chamber 304. For example, inlet 310 may be used to flow medium or cells into culture chamber 304 during a cell seeding, perfusion, or culture phase, but may be used to remove medium, cells, or cell products through inlet 310 during a harvest phase. Thus, the terms "inlet" and "outlet" are not intended to limit the function of those openings.
[0049] In FIG. 2, the bulk flow direction of fluid through the fixed bed in bioreactor 300 is from inlet 310 to outlet 312, and in this example, the first and second major surfaces of substrate layer 308 are perpendicular to the bulk flow direction.
[0050] The cell culture matrix can be arranged in a number of configurations within the culture chamber, depending on the system desired. For example, in one or more embodiments, the system includes one or more layers of substrates having a width that spans the width of a defined cell culture space within the culture chamber. Multiple substrates can be stacked in this manner to a predetermined height. As previously mentioned, the substrate layers can be arranged such that a first and second surface of one or more layers are perpendicular to the bulk flow direction of the medium through the defined culture space within the culture chamber, or the first and second surfaces of one or more layers can be parallel to the bulk flow direction. In one or more embodiments, the cell culture matrix includes one or more substrate layers in a first orientation relative to the bulk flow and one or more other layers in a second orientation different from the first orientation. For example, the various layers can have first and second surfaces parallel or perpendicular to the bulk flow direction, or at an angle therebetween.
[0051] In one or more embodiments, the cell culture system includes a plurality of individual pieces of cell culture substrate in a packed bed configuration, where the length and / or width of the substrate pieces are small relative to the culture chamber. As used herein, a substrate piece is considered to have a length and / or width that is small relative to the culture chamber if the length and / or width of the substrate piece is about 50% or less of the length and / or width of the culture space. Thus, the cell culture system may include a plurality of substrate pieces packed into the culture space in a desired arrangement. The arrangement of the substrate pieces may be random or semi-random, or may have a predetermined order or alignment, such as the pieces being oriented in a substantially similar orientation (e.g., horizontally, vertically, or at an angle between 0° and 90° relative to the bulk flow direction).
[0052] As used herein, a "defined culture space" refers to the space within the culture chamber that is occupied by the cell culture matrix and in which cell seeding and / or culturing is to occur. The defined culture space can fill substantially all of the culture chamber or may occupy a portion of the space within the culture chamber. As used herein, a "bulk flow direction" is defined as the direction of bulk mass flow of fluid or medium through or over the cell culture matrix during culturing of cells and / or during flow of medium into or out of the culture chamber.
[0053] In one or more embodiments, the cell culture matrix is secured within the culture chamber by a securing mechanism. The securing mechanism may secure a portion of the cell culture matrix to a wall of the culture chamber surrounding the matrix or to a chamber wall at one end of the culture chamber. In some embodiments, the securing mechanism attaches a portion of the cell culture matrix to a member extending through the culture chamber, such as a member extending parallel to the longitudinal axis of the culture chamber or a member extending perpendicular to the longitudinal axis. However, in one or more other embodiments, the cell culture matrix may be contained within the culture chamber without being fixedly attached to a wall of the chamber or bioreactor vessel. For example, the matrix may be contained such that the boundaries of the culture chamber or other structural members within the chamber hold the matrix within a predetermined area of the bioreactor vessel without the matrix being rigidly secured to those boundaries or structural members.
[0054] The bioreactor vessel may optionally include one or more outlets that may be attached to inlet and / or outlet means through which fluid, medium or cells may be supplied to or removed from the chamber. A single port on the vessel may serve the function of both inlet and outlet, or multiple ports may be provided for dedicated inlets and outlets.
[0055] The packed-bed cell culture matrix of one or more embodiments may be comprised of a woven cell culture mesh substrate without any other form of cell culture substrate disposed within or interspersed within the cell culture matrix. That is, the woven cell culture mesh substrate of the disclosed embodiments is an effective cell culture substrate that does not require the type of irregular non-woven substrates used in existing solutions. This allows for cell culture systems of simplified design and construction while still providing high density cell culture substrates with other advantages discussed herein related to flow uniformity, harvestability, etc.
[0056] As described herein, the cell culture substrates and bioreactor systems provided offer numerous advantages. For example, the disclosed embodiments can support the production of any of a number of viral vectors, such as AAV (all serotypes) and lentivirus, and can be applied for in vivo and ex vivo gene therapy applications. Uniform cell seeding and distribution maximizes viral vector yield per vessel, and the design allows for viable cell harvest, which can be useful for seed trains consisting of multiple deployment periods using the same platform. In addition, the embodiments herein are scalable from process development scale to production scale, ultimately saving development time and costs. The methods and systems disclosed herein also enable automation and control of the cell culture process to maximize vector yield and improve reproducibility. Finally, the viral vectors can be scaled to production levels (e.g., 10 per batch). 16 From 10 18 The number of vessels required to reach a single AAV volume (µg) can be significantly reduced compared to other cell culture solutions.
[0057] It is desirable to be able to monitor a bioreactor used to culture cells and / or generate viral products and / or create a seed train to promote cell growth for biochemical production. When using adherent cells in a bioreactor, samples of the growth medium will not contain cells, and therefore cell culture or cell count cannot be measured in the exiting medium. To be able to predict the number of cells and their distribution in an adherent cell culture fixed bed, one method is to remove a portion of the substrate during the cell growth process, according to an embodiment of the present disclosure. By sampling during the cell culture process, information about the run can be used to evaluate the quality and performance of the culture process. Cell count can be predicted from the samples, and growth can be monitored by sampling at different times. This information can be used to develop and optimize the performance of certain biological processes, such as seed trains and viral vector production. In production, contaminated or out-of-specification runs can be terminated, reducing the cost of running the process to completion without satisfactory results. Growth medium and lost production time are significant costs for a typical biological process.
[0058] Thus, the present disclosure describes a method for cutting and perforating substrates and layers of cell culture substrates, including polymeric mesh substrates, to create removable sample portions. The present disclosure also describes a method and apparatus for aseptically removing samples from a bioreactor. By sampling during a cell culture process, information about the performance can be used to evaluate the quality and performance of the culture process. Cell numbers can be inferred from samples, and growth can be monitored by sampling at different times or at different locations in the bioreactor. This information can be used to develop and optimize parameters of certain biological processes, such as seed trains and viral vector production. In production, contaminated or off-specification processes can be aborted to reduce the cost of running the process to completion without satisfactory results. Growth medium and lost production time are significant costs for a typical biological process.
[0059] In embodiments herein, the sample portion of the substrate is separable from the remainder of the cell culture substrate with low force, ideally for manual sampling, without disturbing the primary mesh during the sampling process. For example, a relatively small (e.g., manually applied) force can separate the sample portion from the remainder of the substrate due to tension between the sample portion to which the force is applied and the remainder of the substrate. To keep removal forces low, a separation boundary can be implemented between the sample portion and the remainder of the substrate. This separation boundary can be formed, for example, by scoring, drilling, laser cutting, or other cutting means such as punching, and can be used to create a layer of substrate that includes a detachable piece of substrate that can be removed from the fixed bed.
[0060] In some embodiments, a woven polymer mesh substrate is used having woven fibers that define an ordered array of pores or openings. Because each fiber in the mesh can be very strong, it is sometimes desirable to have no fibers extending between the removable sample and the main body of the mesh to facilitate removal of the sample with less force. It may also be desirable for the mesh layer to be sturdy when handled during the manufacturing and assembly processes used to create the mesh laminate bioreactor bed. To accomplish this, some fibers can be cut in a manner that leaves a woven portion of the mesh connecting the sample to the main body of the mesh, as shown in FIG. 3A. Due to the relative stiffness of the fibers, which can be formed from the various polymers disclosed herein (including PET), the interwoven fibers remain attached even though individual fibers are cut, creating a separation boundary for the sample portion. The line in FIG. 3A indicates the separation boundary 402. FIG. 3B shows the sample portion after it has been removed from the remainder of the cell culture substrate.
[0061] The mesh layer with the sample pieces cut off can be removed from the bioreactor by opening the bioreactor housing and pulling them from the floor with a sanitized instrument, or they can be removed from the reactor by using a sterile sampling port.
[0062] A variety of sample collection pieces can be derived from a single layer. In embodiments using a woven substrate, it is believed that for most cutting patterns, the weave and warp orientation when engaging the cutting pattern will maintain structural integrity and allow for easy removal. Some cutting patterns created are less sensitive to mesh fiber orientation, and it is advantageous to use these patterns for manufacturing, as mesh orientation does not need to be precisely controlled.
[0063] 4A-4C show an example of an embodiment in which the sampling layer includes multiple sampling portions. The shape of the sampling portion includes a rectangular end on the inside of the sampling portion that is inboard of the periphery of the sampling layer, and a tapered end on the outside end of the periphery of the sampling layer. The tapered end allows for easy removal of the sampling portion through a port 424 in the sidewall of the bioreactor. The substrate material is such that the size of the port in the sidewall can be the same or slightly larger than the narrow end side, allowing the wider portion of the sampling portion to fold or curve slightly as it is pulled through the opening in the sidewall. FIG. 4B shows a close-up of an individual sampling portion 422 after it has been removed, and FIG. 4C shows an example of the relative size between the sidewall port 424 in the bioreactor and the sampling portion 422, although the relative sizes may vary in various embodiments.
[0064] The sterile port assembly can be modular so that sample collection locations can be added to the reactor at any height and orientation. FIG. 5A shows three layers of four sample ports assembled on a bioreactor vessel. FIG. 5B is a plan view through line AA of FIG. 5A and an exploded view of the port fittings in the sidewall of the bioreactor. These port fittings can be used to attach a sterile capture mechanism to the exterior of the vessel to capture sample portions and maintain them in a sterile environment. Embodiments of the present disclosure include devices and methods for sterilely collecting samples from a cell culture bioreactor during the course of cell culture. The embodiments include reels or rotating drums connected to ports in the sidewall of the bioreactor. By rotating these reels, sample substrates can be aseptically removed from the bioreactor and then removed from the reels for analysis of cell count and the progress and / or health of the culture.
[0065] FIG. 6A shows an isometric view of a cell culture bioreactor 500 with a series of sampling reels 502 on the side of the bioreactor 500, according to an embodiment. As shown in FIG. 6A, multiple substrate samples 504 extend from the sampling reels 502, indicating that the substrate samples 504 have been removed by the reels from the interior of the bioreactor vessel and are ready for collection and analysis. FIG. 6B shows a close-up view of one of the sampling reels 502 from FIG. 6A, according to an embodiment. For clarity, the walls of the bioreactor vessel are not shown in FIG. 6B, but the through openings 505 to the ports in the bioreactor can be seen. It is through the through openings 505 that the substrate samples pass from the bioreactor vessel to the sampling reels 502.
[0066] Additional details of the sampling reel 502 are shown in the cross-sectional view of Figure 7. The sampling reel 502 is secured to the bioreactor vessel wall 501 by a saddle housing 506 such that the through opening 505 of the sampling reel 502 aligns with a port in the bioreactor vessel wall 501. The remainder of the shell of the sampling reel 502 is made from a housing cap 508. A sample opening 516 is left between the housing cap 508 and the saddle housing 506 through which the substrate sample will originate (as shown in Figure 6A). Within the sampling reel 502 is a spool 510 that is made to grip a portion of the sample substrate 504 such that the sample substrate 504 is wound around the spool 510 as the spool 510 rotates. The sampling reel 502 also includes a sample drum 512 disposed between the spool 510 and the outer housing (saddle housing 506 and housing cap 508) of the sampling reel 502. A series of stationary O-rings 514 are secured to the saddle housing 506 to create a seal in the space between the saddle housing 506 and the sample drum 512 to allow for sterile sampling of the sample substrate 504. The sample drum 512 also includes a drum opening 518 that allows the sample substrate to pass through the sample drum 512 to the spool 510. As described below, the drum opening 518 will also allow for removal of the sample substrate from the sampling reel 502.
[0067] FIG 8A is a cross-sectional view of the sampling reel 502 of FIG 7 as it is rotated clockwise (as viewed on the page) to remove the sample substrate 504 through the through opening 505, according to an embodiment. As shown in FIG 8B, after the sampling reel 502 has been rotated sufficiently to pass all of the sample substrate 504 through the through opening 505, the sample substrate 504 is then removed completely from the interior of the bioreactor vessel and retained within the sampling reel 502. As shown in FIG 9A, according to an embodiment, further rotation in the same direction aligns the substrate sample opening 516 with the through opening 505 to allow removal of the substrate sample 504. To remove the sample substrate 504, the spool 510 is then rotated in the opposite direction (counterclockwise on the page in FIG 9B). The sample drum 512 remains in place during reverse rotation and the substrate sample 504 is pushed out of the sampling reel 502 through the through opening 505 and the sample opening 516. Removal of the substrate sample 504 through these openings can be assisted by curved or wedge surfaces on the edges of the through opening 505, as shown in FIG.
[0068] The sample drum 512 is rotated until the entire substrate sample 504 is removed from the sampling reel 502, as shown in Figures 10A and 10B. Figure 10B also shows that it can be further rotated in a counterclockwise direction (page of Figure 10B) to seal the interior of the sampling reel 502 with the drum opening 518 passing through the stationary O-ring 514 near the sample opening 516. The entire mechanism can therefore deliver the substrate sample in a sterile condition without exposing the interior of the bioreactor vessel. For clarity, Figures 11A-11C show an isometric view of the sample drum 512 and stationary O-ring 514 without the housing cap 508 and saddle housing 506 so that it can be appreciated how the drum opening 518 passes through a series of O-rings on the way to align with the sample opening 516 in Figure 11C.
[0069] According to the embodiments described herein, sterile sampling can be performed at any location within the cell culture fixed bed substrate. The sample portion can then be analyzed under appropriate conditions after being removed from the bioreactor. This process limits the exposure of the sample to potential contamination of the main cell culture that would occur if the entire bioreactor had to be opened and a portion of the substrate removed (which would also physically disturb the cells in the portion of the cell culture that is reinserted into the bioreactor).
[0070] According to embodiments of the present disclosure, a multi-layer cell culture substrate assembly is provided that facilitates sampling of multiple layers at predetermined locations along the height of the assembly. In embodiments, the cell culture substrate stack is disposed within a sleeve with a predetermined sample access slot. The cell culture substrate stack can be lifted from the housing of the vessel while still within the sleeve, and the layers of substrate can be removed from the assembly through the predetermined sample access slot. Aspects of the embodiments also include a seal on the sleeve adjacent the sample access slot to prevent bypass flow within the vessel around the substrate bed. The closure of the sleeve can be adjustable to accommodate substrate layers of varying diameters.
[0071] FIG. 12A shows an isometric view of a multi-layer cell culture substrate assembly in a sleeve with cutouts for sample collection, according to an embodiment. The assembly includes a multi-layer stack of substrate layers 600 and a sleeve 602 wrapped around the substrate layers with predefined sample access slots 604 along the height of the assembly. By spacing the sample access slots 604 along the height of the assembly, samples can be collected from various locations within the fixed bed (e.g., bottom, middle, and top) to account for potential variations due to different locations within the fixed bed. FIG. 12B shows a top view of the assembly of FIG. 12A. FIG. 13A shows an isometric view of the assembly of FIG. 12A with a seal 606 added along the predefined sample access slots, according to an embodiment. FIG. 13B shows a top view of the assembly of FIG. 13A. FIG. 14A shows an isometric view of the assembly of FIG. 13A placed within an outer housing 608 of a bioreactor vessel, according to an embodiment. The seal 606 can seal the space between the sleeve 602 and the outer housing 608 to prevent bypass fluid flow from the sample access slot and around the cell culture substrate. The seal 606 may form an interference fit with the outer housing 608 or there may be a groove or gasket to form an interference fit with the seal 606. Figure 14B shows a top view of the assembly of Figure 14A.
[0072] 15, if a sample needs to be collected from the assembly of FIG. 14A, according to an embodiment, the multi-layer cell culture substrate layer 600 and sleeve 602 can be lifted out of the outer housing 608 so that sample access slot 604 can be accessed and the sample substrate layer 601 can be removed through sample access slot 604 for sampling. After any sample substrate layer 601 has been collected, the assembly can be reinserted into the outer housing and cell culture can continue.
[0073] 16 is a plan view of a substrate sample 600 and a sleeve 602 wrapped around the substrate, according to an embodiment. In some embodiments, the sleeve 602 may not completely wrap around the substrate at a given location, thereby forming a sample access slot. Thus, the sample access slot 604 is a window formed in the sleeve 602 and may be sized to adequately retain the substrate layer within the window, yet still allow the substrate to be removed during sampling. For example, the opening of the sample access slot 604 or window may be slightly narrower than the maximum width of the substrate layer.
[0074] 17 shows an example where a sample layer of substrate 480 has a tether 482 molded (484) to the sample portion so that the sample portion can be removed by pulling the tether 482. An embodiment includes a method of assembling a bioreactor where a layer of substrate is added to the bioreactor housing until it reaches the height of the sampling port. At this point, the sampling layer is inserted into the bioreactor vessel and the tether is pulled through the port. A sterile vessel external to the port can be used to perform sterile sampling.
[0075] FIG. 18A shows a sample layer with six pie-shaped sample collection portions. The number and shape of the sample collection portions can vary. In this case, a separation boundary is laser cut through the fibers of the woven mesh substrate. The sample layer also includes an alignment feature on the left side of the layer, which can be useful for holding the sample layer in place so that the sample collection portions are in place to facilitate sampling. This alignment feature can be designed to mate with a corresponding feature on the interior of the container sidewall. FIG. 18B shows three pie-shaped sample portions stained to indicate the presence of adherent cells on the substrate. FIG. 18C shows the three sampled pie-shaped sample portions after a harvesting procedure to harvest cells from the substrate. Comparing FIG. 18B and 18C shows the effectiveness of the harvesting procedure in this example.
[0076] 19A shows a cross-sectional view of a sample capture device 600, according to an embodiment. The sample capture device 600 has an interior space 602 for sterilely capturing and holding a sample portion of a cell culture substrate 610 held within a bioreactor 612. The capture device 600 is coupled to a port 614 through which a tether 616 passes into the interior of the bioreactor 612, where the tether is attached to the sample portion. A seal 618 or overmold is placed within the port at the inlet of the bioreactor 612 to prevent fluid from exiting through the port 614 while the bioreactor is in use. The other side of the tether 616 may be placed within the capture device 600 or may be coupled to the end of the capture device 600 opposite the port 614. When it is desired to take a sample, the end of the capture device with the tether 616 attached can be pulled until the tether 616 pulls the sample portion 619 (FIG. 19B) out of the bioreactor 612 and the sample portion 619 is located within the capture device 600. According to an embodiment, the sample substrate layer can be scored according to the embodiments described above, so that the sample portion 619 can be easily removed. The capture device 600 can be fabricated from a flexible and / or deformable material, such as a polymeric film or bag. In an embodiment, the capture device 600 can resemble a "bellows" device with folds or pleats. When the bellows is extended, the plug is removed and the mesh is pulled into the bellows by the tether. Using these types of capture devices for aseptic sampling, a portion of the substrate can be removed from the edge of the fixed bed substrate at any height within the bed without risk of contaminating the bulk cell culture. The design allows the sample portion of the fixed bed to be easily removed from the housing, giving the user access to the bed without destroying the bed or the bioreactor vessel, allowing any portion of the bed to be evaluated. The housing can also be cleaned and reused.
[0077] 19B shows a cross-sectional view of the sample capture device 600 during capture of a sample portion. After removal of the sample portion 619 from the bioreactor, to maintain sterility of the sample collection, the portion of the sample capture device 600 near the port 614 can be sealed, as shown by arrow A, by a closing mechanism built into the sample capture device 600 or by applying force and / or heat to seal the two sides of the capture device to each other (e.g., by using an RF or heat tube sealer). Other means of sealing the port are also contemplated according to embodiments, including caps, collapsible ports, sliding or hinged covers, or other means suitable for sealing the port and maintaining the integrity of the cell culture in the bioreactor.
[0078] 19C shows a cross-sectional view of a bioreactor 632, according to an embodiment. In this drawing, two sterile sample collection ports 634 are shown, but it should be recognized that the bioreactor 632 may contain additional ports not shown in this drawing along the height of the bioreactor and around the periphery of the bioreactor, thus allowing the user to sample from various locations in the cell culture matrix. In the process of assembling the cell culture substrate 630 into the bioreactor 632, layers of substrates can be stacked within the bioreactor 632 until the height of the ports 634 is reached. At that point, a specially designed substrate layer that is a sample collection substrate (e.g., with a sample portion scored as described above) can be inserted into the stack, and a tether 636 can be inserted through the ports 634 into the space 622 within the capture device 620 and secured to the opposite side of the capture device 620. The tether 636 can be secured by any suitable means, including adhesive, tying the tether to a fixed location on the capture device, threading the tether through a hole on the opposite side of the capture device and securing a cap or fastener that maintains a sterile environment within the space 622 of the capture device 620, or some combination of the above. For example, a sealant can be applied to the hole on the opposite side of the capture device 620 through which the tether 636 passes, where the tether 636 is then tied to a washer or other fastener. The open end of the capture device 620 can then be attached to the port 634 by any suitable means 639, such as a clamp, band, nut, adhesive, thermal seal, or other means.
[0079] 20A-20C show additional aspects of the capture device, according to an embodiment. In FIG. 20A, during assembly, a tether 700 is secured to the sample collection mesh layer. The tether 700 is overmolded with a plug 702, and a port 704 is closed with a cap or plug 706 until a sample is to be collected. The sample capture device 710 is maintained separate from the bioreactor. As in the example of FIGS. 19A-19C, the capture device 710 has an opening 712 through which a second tether 714 passes. Near the opening 712, the second tether 714 is provided with a fastener 716 or other means for coupling to the tether 700 when the cap 706 is removed and a sample is to be collected. A protective cover 718 can cover the fastener 716 and opening 712 to maintain a sterile environment within the capture device 710 until a sample is to be collected. 20B and 20C, when sample portion 720 is to be harvested, cap 706 is removed, fastener 716 is attached to tether 700, and tube 722 of capture device 710 is attached to port 704. After sample portion 720 is removed and placed within the tube of capture device 710, tube 722 can be sealed 724 as described above.
[0080] 21A-21C show another example of a sealing means according to an embodiment of the present disclosure for closing a port on a bioreactor when a sample is not being taken. The configuration of the capture device and bioreactor in FIG. 21A is similar to that shown in FIG. 19A, and for the sake of brevity, the same features will not be described again. FIG. 21A differs from FIG. 19A in that the capture device 800 extends to the interior of the bioreactor and is attached to a port 802 in the interior wall of the bioreactor. In addition, a valve cam ring 804 is disposed around a portion of the capture device 800 within the port 802. FIG. 21B shows a cross-sectional view of the valve cam ring 804. The valve cam ring 804 functions by pinching or unpinning the portion of the capture device 800 that passes through the valve cam ring 804 as needed. Inside the valve cam ring 804 are ball bearings 806 that crimp the tube of capture device 800 closed when the valve cam ring rotates in one direction due to the surface of the cam and the detents in the valve cam ring 804, and release the tube of capture device 800 when rotated in the opposite direction. Thus, the valve cam ring 804 is opened to remove a sample portion, and then closed after the sample portion is placed in capture device 800, as shown in FIG. 21C. If desired, the tube of capture device 800 can then be sealed by a tube sealer 810 to provide an additional seal to protect the cell culture.
[0081] According to the embodiments described herein, the capture device provides a method for aseptically sampling a sample portion of a cell culture substrate. After the sample portion is removed from the bioreactor, it can then be removed from the capture device under appropriate conditions for analysis. This process limits the exposure of the sample to potential contamination of the main cell culture that would occur if the entire bioreactor had to be opened and a portion of the substrate removed (which would also physically disturb the cells in the portion of the cell culture that is reinserted into the bioreactor).
[0082] definition "Totally synthetic" or "fully synthetic" refers to a cell culture article, such as a microcarrier or culture vessel surface, that is made entirely from synthetic source materials and does not contain any animal-derived or animal-origin materials. The disclosed fully synthetic cell culture articles are free of the risk of xenogeneic contamination.
[0083] Terms such as "including" mean including without limitation, i.e., inclusive and not exclusive.
[0084] "User" refers to a person who uses the systems, methods, articles, or kits disclosed herein, including a person who cultures cells to harvest the cells or cell products, or a person who uses cells or cell products cultured and / or harvested in accordance with the embodiments described herein.
[0085] As used in describing embodiments of the present disclosure, "about" to modify, for example, amounts, concentrations, volumes, process temperatures, process times, yields, flow rates, pressures, viscosities, and similar values and ranges of components in a composition, or dimensions of components, and similar values and ranges, refers to variations in numerical values that may arise, for example, from typical measuring and handling procedures used in preparing a material, composition, composite, concentrate, component, article of manufacture, or formulation for use; from unintentional errors in these procedures; from differences in manufacture, source, or purity of starting materials or components used to carry out the method; and from similar considerations. The term "about" also encompasses amounts that vary with aging of a composition or formulation having a particular initial concentration or mixture, and amounts that vary with mixing or processing of a composition or formulation having a particular initial concentration or mixture.
[0086] "Optionally" or "optionally" means that the subsequently described event or circumstance may or may not occur, and that the description includes instances in which the event or circumstance occurs and instances in which the event or circumstance does not occur.
[0087] A noun includes at least one or more than one object unless otherwise specified.
[0088] Abbreviations well known to those of skill in the art may be used (e.g., "h" or "hrs" for hours, "g" or "gm" for grams, "mL" for milliliters, and "rt" for room temperature, "nm" for nanometers, and similar abbreviations).
[0089] Specific and preferred values and ranges disclosed for components, ingredients, additives, dimensions, conditions, and similar attributes are illustrative only, and they do not exclude other given values or other values within a given range. The systems, kits, and methods of the present disclosure may include any or any combination of the values, specific values, more specific values, and preferred values set forth herein, including explicit or implicit intermediate values and ranges.
[0090] Unless otherwise expressly stated, it is in no way intended that any method set forth herein be construed as requiring that its steps be performed in a particular order. Thus, unless a method claim actually recites the order in which its steps should be followed, or unless the claim or description is otherwise specifically stated to limit the steps to a particular order, no particular order is intended to be implied in any way.
[0091] It will be apparent to those skilled in the art that various modifications and changes can be made without departing from the spirit or scope of the disclosed embodiments. Since modifications, combinations, subcombinations and modifications of the disclosed embodiments that incorporate the spirit and substance of the disclosed embodiments will occur to those skilled in the art, the disclosed embodiments should be construed as including all within the scope of the appended claims and their equivalents.
[0092] Illustrative examples Below are descriptions of various embodiments of implementations of the disclosed subject matter. Each embodiment may include one or more of the various features, characteristics, or advantages of the disclosed subject matter. The implementations are intended to illustrate some embodiments of the disclosed subject matter and should not be considered a comprehensive or exhaustive description of all possible implementations.
[0093] Embodiment 1 relates to a fixed-bed bioreactor assembly for culturing cells, comprising: a bioreactor vessel having an interior space for culturing cells and a sidewall at least partially defining the interior space; a plurality of cell culture substrate layers disposed within the interior space, each layer having a structurally defined surface for culturing cells thereon, the structurally defined surface defining an ordered regular array of openings through a thickness of the layer; and a sleeve at least partially surrounding the plurality of cell culture substrate layers and having at least one sample access window, the sample access window comprising an opening in the sleeve configured to allow one or more layers of cell culture substrate to be removed from the sleeve through the opening.
[0094] Embodiment 2 relates to the fixed-bed bioreactor assembly of embodiment 1, wherein the sleeve and the multiple cell culture substrate layers are removably disposed within the bioreactor vessel.
[0095] Embodiment 3 relates to the fixed-bed bioreactor assembly of embodiment 2, wherein the sleeve and the multiple cell culture substrate layers can at least partially exit the bioreactor vessel together through an opening at the top or bottom of the bioreactor vessel.
[0096] Embodiment 4 relates to a fixed bed bioreactor assembly of embodiment 3, wherein at least one sample access window is free of a side wall of the bioreactor vessel such that one or more layers of the cell culture substrate can be removed for sampling upon at least partial exit from the bioreactor vessel.
[0097] An embodiment 5 relates to the fixed-bed bioreactor assembly of any of embodiments 1-4, wherein the sleeve circumscribes the plurality of cell culture substrate layers.
[0098] Example 6 relates to the fixed-bed bioreactor assembly of Example 5, wherein the sample access window opening is defined in a portion of the sleeve that encircles less of the periphery of the plurality of cell culture substrate layers than another portion of the sleeve.
[0099] Example 7 relates to the fixed-bed bioreactor assembly of any of Examples 1-6, wherein the opening has a width that is less than the maximum width of the one or more layers of the cell culture substrate to be removed.
[0100] Example 8 relates to the fixed-bed bioreactor assembly of any of Examples 1-7, wherein at least one sample access window is disposed at multiple predetermined positions along the height of the bioreactor vessel.
[0101] Example 9 relates to the fixed-bed bioreactor assembly of Example 8, wherein at least one sample access window is disposed in one or more of the bottom region of the bioreactor vessel, the central region of the bioreactor vessel, and the top region of the bioreactor vessel.
[0102] Example 10 relates to the fixed-bed bioreactor assembly of any of Examples 1-9, further comprising one or more seals disposed in the sleeve.
[0103] Example 11 relates to the fixed-bed bioreactor assembly of Example 10, wherein a seal is disposed along the edge of the sample access window opening.
[0104] Example 12 relates to the fixed-bed bioreactor assembly of example 10 or example 11, wherein the seal forms an interference fit with a sidewall of the bioreactor vessel.
[0105] Example 13 relates to the fixed-bed bioreactor assembly of any of Examples 1-12, wherein each layer of the plurality of cell culture substrate layers is made from a plurality of woven fibers.
[0106] Example 14 relates to the fixed-bed bioreactor assembly of any of Examples 1-13, wherein the cell culture substrate comprises multiple layers arranged in a stacked configuration.
[0107] Example 15 relates to a method of sampling a cell culture substrate from a bioreactor vessel, the method including: removing a sleeve of stacked cell culture substrate layers from the bioreactor vessel through a top or bottom of the bioreactor vessel; and removing one or more layers of the cell culture substrate through a sample access window disposed on a side of the sleeve, the sample access window being an opening formed in the sleeve exposing at least a portion of the cell culture substrate layers.
[0108] Example 16 relates to the method of Example 15, further comprising the step of reinserting the sleeve of cell culture substrate layers into the bioreactor vessel after removing the one or more layers.
[0109] Example 17 relates to the method of example 15 or example 16, wherein the step of removing one or more layers is performed during active cell culture.
[0110] Embodiment 18 relates to a fixed-bed bioreactor system for culturing cells, the fixed-bed bioreactor system comprising: a bioreactor vessel having an interior space for culturing cells and a sidewall at least partially defining the interior space; at least one port in the sidewall of the bioreactor vessel; a cell culture substrate disposed within the interior space; and a sampling reel disposed outside the bioreactor vessel, the sampling reel adapted to rotate about a central axis and aseptically remove a sample substrate from the interior space.
[0111] Example 19 relates to the fixed-bed bioreactor system of Example 18, wherein the sampling reel includes a through opening through which a substrate sample can pass from the interior space to the sampling reel.
[0112] Example 20 relates to a fixed-bed bioreactor system of example 18 or example 19, wherein the sampling reel is fixed to the exterior of the bioreactor vessel wall via a saddle housing that forms at least a part of the outer shell of the sampling reel.
[0113] Example 21 relates to the fixed bed bioreactor system of example 19 or example 20, wherein the through opening of the sampling reel is aligned with the at least one port.
[0114] Example 22 relates to the fixed bed bioreactor system of any of Examples 18-21, wherein the sampling reel further comprises a housing cap forming at least a portion of an outer shell of the sampling reel.
[0115] Example 23 relates to the fixed bed bioreactor system of any of Examples 18-22, wherein the sampling reel further comprises a sample opening.
[0116] Example 24 relates to the fixed bed bioreactor system of Example 23, wherein the sample opening is disposed between the housing cap and the saddle housing.
[0117] Example 25 relates to the fixed-bed bioreactor system of example 23 or example 24, wherein the sample opening is configured to allow a substrate sample to be removed from a sampling reel through the sample opening to the outside of the bioreactor system.
[0118] Example 26 relates to the fixed bed bioreactor system of any of Examples 18-25, wherein the sampling reel further includes a spool adapted to grip a portion of the sample substrate, the spool being rotatable such that, as the spool rotates, the sample substrate is wound onto the spool.
[0119] Example 27 relates to the fixed-bed bioreactor system of Example 26, wherein the sampling reel further comprises a sample drum disposed between the spool and the shell of the sampling reel.
[0120] Example 28 relates to the fixed bed bioreactor system of Example 27, wherein the sample collection reel further comprises a series of stationary O-rings secured to the saddle housing and adapted to form a seal in the space between the saddle housing and the sample drum to enable sterile sampling of the sample substrate.
[0121] Example 29 relates to the fixed bed bioreactor system of example 27 or example 28, wherein the sample drum further comprises a drum opening configured to allow the sample substrate to pass through the sample drum to the spool.
[0122] Example 30 relates to the fixed bed bioreactor system of any of Examples 18-29, wherein the sampling reel is configured to rotate in a first direction to remove the sample substrate from the interior space and to rotate in a second direction opposite to the first direction to release the sample substrate from the sampling reel to outside the bioreactor system.
[0123] Example 31 relates to the fixed-bed bioreactor system of any of Examples 18-30, wherein the substrate sample is removed outside the bioreactor system through an opening in the sampling reel by a curved or wedge surface on the edge of the through opening.
[0124] Example 32 relates to the fixed-bed bioreactor system of any of Examples 18-31, wherein the cell culture substrate is made from a plurality of woven fibers.
[0125] Example 33 relates to the fixed-bed bioreactor system of any of Examples 18-32, wherein the cell culture substrate comprises multiple layers arranged in a stacked configuration.
[0126] Example 34 relates to the fixed-bed bioreactor system of any of Examples 18-33, wherein the bioreactor vessel is adapted for aseptic removal of the sample substrate from the interior space.
[0127] Embodiment 35 relates to a fixed-bed bioreactor system for culturing cells, comprising: a bioreactor vessel having an interior space for culturing cells and a sidewall at least partially defining the interior space; at least one port in a sidewall of the bioreactor vessel; and a cell culture substrate disposed within the interior space and having a structurally defined surface for culturing cells thereon, the structurally defined surface defining an ordered regular array of openings through a thickness of the cell culture substrate, at least a portion of the cell culture substrate comprising a sample substrate, the sample substrate being defined by a separation boundary between the sample substrate and a remainder of the cell culture substrate, the separation boundary being configured to separate the sample substrate from the remainder of the cell culture substrate, and the at least one port being sized to allow the sample substrate to be removed from the interior space through the at least one port.
[0128] Example 36 relates to the fixed-bed bioreactor system of example 35, wherein the separation boundary comprises at least one of the following: perforations, cuts in or through the cell culture substrate, or localized thinning thereof.
[0129] Example 37 relates to the fixed bed bioreactor system of example 35 or example 36, wherein the separation boundary further comprises an attachment material between the sample substrate and the remainder of the substrate, the attachment material being configured to detach from one or both of the sample substrate and the remainder of the substrate under tension.
[0130] Example 38 relates to the fixed bed bioreactor system of any of Examples 35-37, further comprising a plurality of sample substrates.
[0131] Example 39 relates to the fixed bed bioreactor system of Example 38, wherein at least two of the plurality of sample substrates are separated from one another by a remaining portion of the cell culture substrate that is not one of the plurality of sample substrates.
[0132] Example 40 relates to the fixed bed bioreactor system of example 38 or example 39, wherein at least a portion of the plurality of sample substrates are separated from one another at a separation boundary without any remaining cell culture substrates therebetween that are not one of the plurality of sample substrates.
[0133] Example 41 relates to the fixed-bed bioreactor system of any of Examples 35 to 40, wherein the cell culture substrate has a circular disc shape.
[0134] Example 42 relates to the fixed-bed bioreactor system of any of Examples 35-41, wherein the sample substrate has at least one of the following shapes: square, rectangular, pie-shaped, or tapered.
[0135] Example 43 relates to the fixed-bed bioreactor system of Example 42, wherein the sample substrate tapers at a narrow tapered end at the outer edge of the cell culture substrate.
[0136] Example 44 relates to the fixed bed bioreactor system of example 42 or example 43, wherein the sample substrate is square or rectangular at a first end of the sample substrate within the periphery of the cell culture substrate and tapers at a second end of the sample substrate at the periphery of the cell culture substrate.
[0137] Example 45 relates to the fixed-bed bioreactor system of Example 42, wherein the cell culture substrate is circular and consists of a plurality of pie-shaped sample substrates.
[0138] Example 46 relates to the fixed bed bioreactor system of any of Examples 35-45, wherein the structurally defined surface is made from one or more fibers.
[0139] Example 47 relates to the fixed-bed bioreactor system of Example 46, wherein the cell culture substrate is made from a plurality of woven fibers.
[0140] Example 48 relates to the fixed-bed bioreactor system of any of Examples 35-47, wherein the cell culture substrate comprises multiple layers arranged in a stacked configuration.
[0141] Example 49 relates to the fixed-bed bioreactor system of any of Examples 35-48, wherein the bioreactor vessel is adapted for aseptic removal of the sample substrate from the interior space.
[0142] Example 50 relates to the fixed bed bioreactor system of any of Examples 35-49, further comprising a tether comprising a first end attached to the sample substrate, the tether configured to pull the sample substrate out of the interior space through the port.
[0143] Example 51 relates to the fixed bed bioreactor system of any of Examples 35 to 50, further comprising a capture device disposed outside the interior space and configured to receive the sample substrate after the sample substrate is removed from the interior space through at least one port.
[0144] Example 52 relates to the fixed-bed bioreactor system of Example 51, wherein the capture device has a flexible wall, pleated wall, or folded structure that allows the capture device to have a variable internal volume.
[0145] Example 53 relates to the fixed bed bioreactor system of any of Examples 50-52, further comprising a plug disposed along the tether between the first and second ends of the tether, the plug being configured to form a sterile seal within the port while the sample substrate remains within the interior space.
[0146] Example 54 relates to the fixed bed bioreactor system of Example 53, wherein the plug is adapted to be removed from the port when the second end of the tether is pulled away from the port with a predetermined force.
[0147] Example 55 relates to the fixed bed bioreactor system of any of Examples 51-54, wherein the capture device is attached to the port at least while the sample substrate remains within the interior space.
[0148] Example 56 relates to the fixed bed bioreactor system of Example 55, wherein the capture device is removably attached to the port.
[0149] Example 57 relates to the fixed-bed bioreactor system of any of Examples 51 to 54, wherein the capture device is separate from the port and the bioreactor vessel, and the capture device is configured to be temporarily attached to the port while the sample substrate is being removed from the interior space through the port.
[0150] Preferred embodiments of the present invention will be described below in detail.
[0151] EMBODIMENT 1 1. A fixed bed bioreactor assembly for culturing cells, comprising: a bioreactor vessel having an interior space for culturing cells and a sidewall at least partially defining the interior space; a plurality of cell culture substrate layers disposed within the interior space, each layer having a structurally defined surface for culturing cells thereon, the structurally defined surface defining an ordered, regular array of openings through a thickness of the layer; and a sleeve at least partially surrounding the plurality of cell culture substrate layers and having at least one sample access window, the sample access window comprising an opening in the sleeve configured to allow one or more layers of the cell culture substrate to be removed from the sleeve through the opening; A fixed bed bioreactor assembly comprising:
[0152] EMBODIMENT 2 2. The fixed-bed bioreactor assembly of embodiment 1, wherein the sleeve and the plurality of cell culture substrate layers are removably disposed within the bioreactor vessel.
[0153] EMBODIMENT 3 3. The fixed-bed bioreactor assembly of embodiment 2, wherein the sleeve and the plurality of cell culture substrate layers can at least partially exit the bioreactor vessel together through an opening at the top or bottom of the bioreactor vessel.
[0154] EMBODIMENT 4 4. A fixed-bed bioreactor assembly as described in embodiment 3, wherein the at least one sample access window, upon at least partial exit from the bioreactor vessel, is free of a side wall of the bioreactor vessel to allow removal of one or more layers of the cell culture substrate for sampling.
[0155] EMBODIMENT 5 5. The fixed-bed bioreactor assembly of any one of the preceding embodiments, wherein the sleeve circumscribes the plurality of cell culture substrate layers.
[0156] EMBODIMENT 6 6. The fixed-bed bioreactor assembly of embodiment 5, wherein the sample access window opening is defined in a portion of the sleeve that encircles less of the periphery of the plurality of cell culture substrate layers than another portion of the sleeve.
[0157] EMBODIMENT 7 7. The fixed-bed bioreactor assembly of any one of the preceding embodiments, wherein the opening has a width that is smaller than the maximum width of one or more layers of the cell culture substrate to be removed.
[0158] EMBODIMENT 8 8. A fixed-bed bioreactor assembly according to any one of the preceding embodiments, wherein the at least one sample access window is arranged at multiple predefined positions along the height of the bioreactor vessel.
[0159] EMBODIMENT 9 9. The fixed-bed bioreactor assembly of embodiment 8, wherein the at least one sample access window is located in one or more of a bottom region of the bioreactor vessel, a central region of the bioreactor vessel, and an upper region of the bioreactor vessel.
[0160] EMBODIMENT 10 10. The fixed-bed bioreactor assembly of any one of the preceding embodiments, further comprising one or more seals disposed in the sleeve.
[0161] EMBODIMENT 11 11. A fixed-bed bioreactor assembly as described in embodiment 10, wherein the seal is disposed along an edge of the opening of the sample access window.
[0162] EMBODIMENT 12 12. A fixed-bed bioreactor assembly according to embodiment 10 or 11, wherein the seal forms an interference fit with a side wall of the bioreactor vessel.
[0163] EMBODIMENT 13 13. The fixed-bed bioreactor assembly of any one of the preceding embodiments, wherein each layer of the plurality of cell culture substrate layers is made from a plurality of woven fibers.
[0164] EMBODIMENT 14 14. The fixed-bed bioreactor assembly of any one of the preceding embodiments, wherein the cell culture substrate comprises a plurality of layers arranged in a stacked configuration.
[0165] EMBODIMENT 15 1. A method for sampling a cell culture substrate from a bioreactor vessel, comprising: removing a sleeve of stacked cell culture substrate layers from the bioreactor vessel through the top or bottom of the bioreactor vessel; removing one or more layers of the cell culture substrate through a sample access window disposed on a side of the sleeve, the sample access window being an opening formed in the sleeve exposing at least a portion of the cell culture substrate layer; The method includes:
[0166] EMBODIMENT 16 16. The method of embodiment 15, further comprising the step of reinserting the sleeve of cell culture substrate layer into the bioreactor vessel after removing the one or more layers.
[0167] EMBODIMENT 17 17. The method of embodiment 15 or 16, wherein the step of removing one or more layers is performed during active cell culture.
[0168] EMBODIMENT 18 1. A fixed bed bioreactor system for culturing cells, comprising: a bioreactor vessel having an interior space for culturing cells and a sidewall at least partially defining the interior space; at least one port in a sidewall of the bioreactor vessel; a cell culture substrate disposed within the interior space; and a sampling reel disposed outside the bioreactor vessel, the sampling reel adapted to rotate about a central axis to aseptically remove a sample substrate from the interior space; A fixed bed bioreactor system comprising:
[0169] EMBODIMENT 19 20. The fixed-bed bioreactor system of embodiment 18, wherein the sampling reel comprises a through opening through which the substrate sample can pass from the interior space to the sampling reel.
[0170] EMBODIMENT 20 20. A fixed-bed bioreactor system according to embodiment 18 or 19, wherein the sampling reel is fixed to the exterior of the bioreactor vessel wall via a saddle housing that forms at least a part of the outer shell of the sampling reel.
[0171] EMBODIMENT 21 21. The fixed bed bioreactor system of embodiment 19 or 20, wherein a through opening of the sampling reel is aligned with the at least one port.
[0172] EMBODIMENT 22 22. The fixed bed bioreactor system according to any one of embodiments 18 to 21, wherein the sampling reel further comprises a housing cap forming at least a part of the outer shell of the sampling reel.
[0173] EMBODIMENT 23 23. The fixed bed bioreactor system of any one of embodiments 18 to 22, wherein the sampling reel further comprises a sample opening.
[0174] EMBODIMENT 24 24. The fixed bed bioreactor system of embodiment 23, wherein the sample opening is located between the housing cap and the saddle housing.
[0175] EMBODIMENT 25 25. A fixed-bed bioreactor system according to embodiment 23 or 24, wherein the sample opening is adapted to allow a substrate sample to be removed from the sampling reel through the sample opening and outside of the bioreactor system.
[0176] EMBODIMENT 26 26. The fixed bed bioreactor system of any one of embodiments 18 to 25, wherein the sampling reel further comprises a spool adapted to grip a portion of the sample substrate, the spool being rotatable such that the sample substrate is wound around the spool as the spool rotates.
[0177] EMBODIMENT 27 27. The fixed-bed bioreactor system of embodiment 26, wherein the sampling reel further comprises a sample drum disposed between the spool and the shell of the sampling reel.
[0178] EMBODIMENT 28 28. The fixed bed bioreactor system of embodiment 27, wherein the sample collection reel further comprises a series of stationary O-rings secured to the saddle housing and adapted to form a seal in the space between the saddle housing and the sample drum to enable sterile sampling of the sample substrate.
[0179] EMBODIMENT 29 30. The fixed bed bioreactor system of embodiment 27 or 28, wherein the sample drum further comprises a drum opening configured to allow the sample substrate to pass through the sample drum to the spool.
[0180] EMBODIMENT 30 30. The fixed bed bioreactor system of any one of embodiments 18 to 29, wherein the sampling reel is configured to rotate in a first direction to remove the sample substrate from the interior space and rotate in a second direction opposite to the first direction to release the sample substrate from the sampling reel to the outside of the bioreactor system.
[0181] EMBODIMENT 31 31. A fixed-bed bioreactor system according to any one of embodiments 18 to 30, wherein the substrate sample is removed outside the bioreactor system through an opening in the sampling reel by a curved or wedge surface at the edge of the through opening.
[0182] EMBODIMENT 32 32. The fixed-bed bioreactor system of any one of embodiments 18 to 31, wherein the cell culture substrate is made from a plurality of woven fibers.
[0183] EMBODIMENT 33 33. The fixed-bed bioreactor system of any one of embodiments 18 to 32, wherein the cell culture substrate comprises a plurality of layers arranged in a stacked configuration.
[0184] EMBODIMENT 34 34. A fixed-bed bioreactor system according to any one of embodiments 18 to 33, wherein the bioreactor vessel is adapted for aseptically removing the sample substrate from the interior space.
[0185] EMBODIMENT 35 1. A fixed bed bioreactor system for culturing cells, comprising: a bioreactor vessel having an interior space for culturing cells and a sidewall at least partially defining the interior space; at least one port in a sidewall of the bioreactor vessel; and a cell culture substrate disposed within said interior space and having a structurally defined surface for culturing cells thereon, said structurally defined surface defining an ordered, regular array of openings through a thickness of said cell culture substrate; Including, at least a portion of the cell culture substrate comprises a sample substrate, the sample substrate being defined by a separation boundary between the sample substrate and a remainder of the cell culture substrate; the separation boundary being configured to separate the sample substrate from the remainder of the cell culture substrate; The at least one port is sized to allow the sample substrate to be removed from the interior space through the at least one port.
[0186] EMBODIMENT 36 36. The fixed-bed bioreactor system of embodiment 35, wherein the separation boundary comprises at least one of the following: perforations, cuts in or through the cell culture substrate, or localized thinning thereof.
[0187] EMBODIMENT 37 37. The fixed bed bioreactor system of embodiment 35 or 36, wherein the separation boundary further comprises an attachment material between the sample substrate and the remainder of the substrate, the attachment material being adapted to detach from one or both of the sample substrate and the remainder of the substrate under tension.
[0188] EMBODIMENT 38 38. The fixed bed bioreactor system of any one of embodiments 35 to 37, further comprising a plurality of sample substrates.
[0189] EMBODIMENT 39 39. The fixed-bed bioreactor system of embodiment 38, wherein at least two of the plurality of sample substrates are separated from each other by a remaining portion of the cell culture substrate that is not one of the plurality of sample substrates.
[0190] EMBODIMENT 40 40. The fixed bed bioreactor system of embodiment 38 or 39, wherein at least a portion of the plurality of sample substrates are separated from one another at the separation boundary without any of the remainder of the cell culture substrates that are not one of the plurality of sample substrates therebetween.
[0191] EMBODIMENT 41 41. A fixed-bed bioreactor system according to any one of embodiments 35 to 40, wherein the cell culture substrate has a circular disc shape.
[0192] EMBODIMENT 42 42. A fixed bed bioreactor system according to any one of embodiments 35 to 41, wherein the sample substrate has at least one of the following shapes: square, rectangular, pie-shaped, or tapered.
[0193] EMBODIMENT 43 43. The fixed-bed bioreactor system of embodiment 42, wherein the sample substrate is tapered at a narrow tapered end at the outer edge of the cell culture substrate.
[0194] EMBODIMENT 44 44. The fixed-bed bioreactor system of embodiment 42 or 43, wherein the sample substrate is square or rectangular at a first end of the sample substrate within the periphery of the cell culture substrate and tapers at a second end of the periphery of the cell culture substrate.
[0195] EMBODIMENT 45 43. The fixed-bed bioreactor system of embodiment 42, wherein the cell culture substrate is circular and consists of a plurality of pie-shaped sample substrates.
[0196] EMBODIMENT 46 46. A fixed bed bioreactor system according to any one of embodiments 35 to 45, wherein the structurally defined surface is made from one or more fibers.
[0197] EMBODIMENT 47 47. The fixed-bed bioreactor system of embodiment 46, wherein the cell culture substrate is made from a plurality of woven fibers.
[0198] EMBODIMENT 48 48. The fixed-bed bioreactor system of any one of embodiments 35 to 47, wherein the cell culture substrate comprises a plurality of layers arranged in a stacked configuration.
[0199] EMBODIMENT 49 49. A fixed-bed bioreactor system according to any one of embodiments 35 to 48, wherein the bioreactor vessel is adapted for aseptic removal of the sample substrate from the interior space.
[0200] EMBODIMENT 50 50. The fixed bed bioreactor system of any one of embodiments 35 to 49, further comprising a tether including a first end attached to the sample substrate, the tether configured to pull the sample substrate out of the interior space through the port.
[0201] EMBODIMENT 51 51. The fixed bed bioreactor system of any one of embodiments 35 to 50, further comprising a capture device disposed outside the interior space and configured to receive the sample substrate after it is removed from the interior space through the at least one port.
[0202] EMBODIMENT 52 52. The fixed-bed bioreactor system of embodiment 51, wherein the capture device has a flexible wall, a pleated wall, or a folded structure that allows the capture device to have a variable internal volume.
[0203] EMBODIMENT 53 53. The fixed bed bioreactor system of any one of embodiments 50 to 52, further comprising a plug disposed along the tether between the first and second ends of the tether, the plug being configured to form a sterile seal within the port while the sample substrate remains within the interior space.
[0204] EMBODIMENT 54 54. The fixed bed bioreactor system of embodiment 53, wherein the plug is configured to be removed from the port when the second end of the tether is pulled away from the port with a predetermined force.
[0205] EMBODIMENT 55 55. The fixed bed bioreactor system of any one of embodiments 51 to 54, wherein the capture device is attached to the port at least while the sample substrate remains within the interior space.
[0206] EMBODIMENT 56 56. The fixed bed bioreactor system of embodiment 55, wherein the capture device is removably attached to the port.
[0207] EMBODIMENT 57 55. A fixed bed bioreactor system according to any one of embodiments 51 to 54, wherein the capture device is separate from the port and the bioreactor vessel, and the capture device is adapted to be temporarily attached to the port during removal of the sample substrate from the interior space through the port. [Explanation of symbols]
[0208] 100 base 102 first plurality of fibers 104 second plurality of fibers 106 Aperture 108 Front page 110 Second side 300 Cell Culture System 302 Bioreactor vessel 304 Cell Culture Chamber 306 Cell Culture Matrix 308, 600 Base layer 310 Entrance 312 Exit 402 Separation Boundary 422 Sampling area 424 Sidewall Port 480 Base 482, 616, 700 Tether 500, 612, 632 Bioreactors 502 Sampling Reel 504 Multiple sample substrates 505 Through opening 506 Saddle Housing 508 Housing Cap 510 Spool 512 Sample drum 514 Stationary O-ring 516 Sample opening 518 Drum opening 600, 620, 710, 800 Capture device 601 Sample substrate layer 602 Sleeve 604 Sample Access Slot 606 Seal 608 Outer housing 610 Cell culture substrate 614, 704, 802 ports 618 Seal 619, 720 Sample part 620 Space 634 Sterile sample collection port 706 Stopper 716 Fasteners 718 Protective Cover 722 tube 804 Valve Cam Ring 806 Ball Bearing 810 Tube Sealer
Claims
1. 1. A fixed bed bioreactor system for culturing cells, comprising: a bioreactor vessel having an interior space for culturing cells and a sidewall at least partially defining the interior space; at least one port in a sidewall of the bioreactor vessel; and a cell culture substrate disposed within said interior space and having a structurally defined surface for culturing cells thereon, said structurally defined surface defining an ordered, regular array of openings through a thickness of said cell culture substrate; Including, at least a portion of the cell culture substrate comprises a sample substrate, the sample substrate being defined by a separation boundary between the sample substrate and a remainder of the cell culture substrate; the separation boundary being configured to separate the sample substrate from the remainder of the cell culture substrate; The at least one port is sized to allow the sample substrate to be removed from the interior space through the at least one port.
2. 2. The fixed bed bioreactor system of claim 1, wherein the separation boundary comprises at least one of the following: perforations, cuts in or through the cell culture substrate, or localized thinning thereof.
3. 2. The fixed bed bioreactor system of claim 1, wherein the separation boundary further comprises an attachment material between the sample substrate and the remainder of the substrate, the attachment material being adapted to detach from one or both of the sample substrate and the remainder of the substrate under tension.
4. 10. The fixed bed bioreactor system of claim 1 further comprising a plurality of sample substrates.
5. 5. The fixed bed bioreactor system of claim 4, wherein at least two of said plurality of sample substrates are separated from one another by a remaining portion of said cell culture substrate that is not one of said plurality of sample substrates.
6. 2. The fixed bed bioreactor system of claim 1, wherein said cell culture substrate has a circular disk shape.
7. 10. The fixed bed bioreactor system of claim 1, wherein the sample substrate has at least one of the following shapes: square, rectangular, pie-shaped, or tapered.
8. 8. The fixed bed bioreactor system of claim 7, wherein said sample substrate is tapered at a narrow tapered end at an outer periphery of said cell culture substrate.
9. 8. The fixed bed bioreactor system of claim 7, wherein the sample substrate is square or rectangular at a first end of the sample substrate within a periphery of the cell culture substrate and is tapered at a second end of the sample substrate within a periphery of the cell culture substrate.
10. 8. The fixed bed bioreactor system of claim 7, wherein said cell culture substrate is circular and comprises a plurality of pie-shaped sample substrates.
11. the structurally defined surface being made from a plurality of woven fibers; 10. The fixed bed bioreactor system of claim 1, wherein the cell culture substrate comprises a plurality of layers arranged in a stacked configuration.
12. 10. The fixed bed bioreactor system of claim 1, wherein said bioreactor vessel is adapted for aseptic removal of said sample substrate from said interior space.
Citation Information
Patent Citations
Packed bed bioreactor
US4833083A
Method and apparatus for anchorage and suspension cell culture
US5501971A
Cell-culturing apparatus and method employing a macroporous support
US5510262A
Large scale cell harvesting method for pack-bed culture device
US9273278B2
